Aroa Biosurgery Share Price and Company Fundamentals
Last traded: Today at 3:01 AM
Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and selling of medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction. The company was incorporated in 2007 and is headquartered in Auckland, New Zealand.
|Primary activities||Designing and selling regenerative healing products|
|Industry / Sector||Medical Devices / Healthcare|
|Mailing address||64 Richard Pearse Drive Airport Oaks Mangere Auckland 2022 New Zealand|
|Phone / Fax||64 9 869 3035 /|
|Share registry||BOARDROOM PTY LIMITED|
Aroa Biosurgery does not pay dividends.
As of Aug 2021, following are the company executives and directors listed on Aroa Biosurgery.
|Dr. Brian Ward||Founder, CEO, MD & Exec. Director||400.99k|
|Mr. James Agnew||CFO & Joint Company Sec.||265.81k|
|Ms. Simone Von Fircks||VP of Operations|
|Dr. Barnaby C.H. May||VP of Technology|
|Ms. Tracy Weimar BA, MBA||Company Sec.|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Aroa Biosurgery is 334.19M and its enterprise value is 323.6M. The enterprise value to revenue ratio of ARX is 14.48.
Companies similar to Aroa Biosurgery (ARX)
Aroa Biosurgery (ASX:ARX) Frequently Asked Questions
1. What is Aroa Biosurgery's Stock Symbol?
Aroa Biosurgery trades on ASX under the ticker symbol "ARX".
2. What is Aroa Biosurgery's stock price today?
One share of ARX stock can currently be purchased for approximately $1.11.
3. How can I contact Aroa Biosurgery?
Aroa Biosurgery's mailing address is 64 Richard Pearse Drive Airport Oaks Mangere Auckland 2022 New Zealand. The company can be reached via phone at 64 9 869 3035.
4. What is Aroa Biosurgery's official website?
The official website of Aroa Biosurgery is http://aroabio.com.
5. Which share registry manages Aroa Biosurgery's stock?
Aroa Biosurgery's stock is managed by BOARDROOM PTY LIMITED.